Effects of contraception methods on female sexual function and quality of life

Abstract

Aim: Many women of reproductive age who use contraceptive methods have sexual dysfunction and reduced quality of life. This study aimed to evaluate the effects of various contraceptive methods on female sexual function index (FSFI) and quality of life scale (SF-12). Methods: This prospective observational study was conducted on the patients admitted to the Gynecology and Obstetrics outpatient clinic between August and October 2020. FSFI total score and FSFI sub-domains (desire, arousal, lubrication, orgasm, satisfaction, and pain) and SF- 12 were used to compare the differences between the groups using various contraceptive methods (Mirena, Copper RIA, tubal ligation, condom, and oral contraceptive pill). The demographic characteristics of the patients, the FSFI, and SF-12 data were collected by the researchers face to face. Results: A total of 228 subjects with a mean age of 30.32 years participated in the study. FSFI scores of the patients using and not using contraceptive methods were significantly different (P<0.001), while PCS-12 (P=0.122) and MCS-12 (P=0.122) scores were similar. The mean total FSFI score was 23.36. Conclusion: The study concluded that women using contraceptive methods had lower total FSFI scores than those who did not, and statistically significant differences were found between the two groups in terms of lubrication, desire, and pain subdomains. We found that contraception methods significantly affected the sexual function of women, but not their quality of life.

Keywords

• Female Sexual Dysfunction
• Sexual Function
• Quality of Life
• Contraception
• Female Sexual Function Index

Kontrasepsiyon yöntemlerinin kadın cinsel fonksiyonu ve yaşam kalitesi üzerindeki etkisi

Öz

Amaç: Bu çalışmamızda, kontrasepsiyon yöntemlerinin kadın cinsel fonksiyonuna ve yaşam kalitesine etkisinin, Kadın Cinsel Fonksiyon Ölçeği (KCFÖ) ve Yaşam Kalitesi Ölçeği (SF-12) doğrultusunda ölçülmesi amaçlandı. Yöntemler: Bu prospektif gözlemsel araştırmaya, Ağustos-Ekim 2020 tarihleri arasında Kadın hastalıkları ve doğum polikliniğimize başvuran hastalar dahil edildi. KCFÖ ve alt grupları skorları (arzu, uyarılma, lubrikasyon, orgasm, memnuniyet ve ağrı ) ile SF-12 skorları korunma yöntemleri (Mirena, Bakır RIA, tüp ligasyonu, kondom, ve oral kontraseptif hap) kullananlar ile kullanmayanların cinsel işlevleri ve yaşam kaliteleri açısından farklılık olup olmadığını araştırmak amacıyla kullanıldı. Hastaların demografik özellikleri, KCFÖ ve SF-12 skorları araştırmacılar tarafından yüz yüze toplandı. Bulgular: Çalışmaya 228 kişi dahil edildi, çalışmaya katılan kadınların ortalama yaşı 30,32 saptandı. Toplam KCFÖ skoru bakımından, gruplar arasında istatistiksel olarak anlamlı bir fark söz konusudur (P<0,001). Ortalama toplam KCFÖ skoru 23.36 olarak ölçüldü. PCS-12 (P=0,122) ve MCS-12 (P=0,122) arasında istatistiksel olarak anlamlı bir fark tespit edilmedi. Sonuç: Kontrasepsiyon yöntemi kullanan kadınların, kontrasepsiyon yöntemi kullanmayan kadınlara göre daha düşük toplam KCFÖ skorlarına sahip olduğu ve her iki grubun da arzu, lubrikasyon ve ağrı alt gruplarında istatistiksel olarak anlamlı bir fark bulunduğu gösterildi. Kontrasepsiyon yöntemleri kadın cinsel fonksiyon bozukluğu üzerinde önemli bir etkiye sahipken, kadınların yaşam kalitesi kontrasepsiyon yöntemlerinden etkilenmemektedir.

Anahtar Kelimeler

• Kadın cinsel fonksiyon bozukluğu
• Yaşam kalitesi
• Doğum kontrolü
• Kadın cinsel fonksiyon ölçeği

Kaynakça

1. 1. Sakinci M, Ercan CM, Olgan S, Coksuer H, Karasahin KE, Kuru O. Comparative analysis of copper intrauterine device impact on female sexual dysfunction subtypes. Taiwan J Obstet Gynecol. 2016;55(03):460-1.
2. 2. Kütmeç C. Kadınlarda cinsel fonksiyon bozukluğu ve hemşirelik bakımı. Fırat Sağlık Hizmetleri Dergisi. 2009;4(12):111-36.
3. 3. Kingsberg S, Woodard T. Female sexual dysfunction: focus on low desire. Obstet Gynecol. 2015;125(2):477-86.
4. 4. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women:prevalence and correlates. Obstet Gynecol. 2008;112(5):970-8.
5. 5. Kohn IJ, Kaplan SA. Female sexual dysfunction: What is known and what remains to be determined. Contemporary Urology 1999;9:54-72.
6. 6. Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women:results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther. 1993;19(3):171-88.
7. 7. Aygin D, Aslan FE. Turkish adaptation of the Female Sexual Function Index. Türkiye Klinikleri. J Med Sci.2005;25(3):393-99.
8. 8. Biddle AK, West SL, D'Aloisio AA, Wheeler SB, Borisov NN, Thorp J. Hypoactive sexual desire disorder in postmenopausal women:quality of life and health burden. Value Health. 2009;12(5):763-72.

9. 9. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004;1(1):35-9.
10. 10. Li RH, Lo SS, Teh DK, Tong NC, Tsui MH, Cheung KB, et al. Impact of common contraceptive methods on quality of life and sexual function in Hong Kong Chinese women. Contraception. 2004;70(60):474-82.
11. 11. Sadatmahalleh SJ, Ziaei S, Kazemnejad A, Mohamadi E. Evaluation of sexual function and quality of life in Iranian women with tubal ligation: a historical cohort study. Int J Impot Res. 2015;27(5):173–7.
12. 12. Smith A, Lyons A, Ferris J, Richters J, Pitts M, Shelley J. Are sexual problems more common in women who have had a tubal ligation? A population-based study of Australian women. BJOG. 2010;117(4):463–8.
13. 13. Skrzypulec V, Drosdzol A. Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system Mirena. Coll Antropol. 2008;32(4):1059-68.
14. 14. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537-44.
15. 15. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI):a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.
16. 16. Yaylali GF, Tekekoglu S, Akin F. Sexual dysfunction in obese and overweight women. Int J Impot Res. 2010;22(4):220-6.
17. 17. Oksuz E, Malhan S. The reliability and validity of Turkish version of female sexual function index. Sendrom. 2005;17(7):54-60.
18. 18. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B:How to Score Version 2 of the SF-12 Health Survey (With a Supplement Documenting Version 1). Lincoln, RI:QualityMetric Incorporated;2002.
19. 19. Safarinejad MR. Female sexual dysfunction in a population-based study in Iran:prevalence and associated risk factors. Int J Impot Res. 2006;18(4):382‐95.
20. 20. Koseoglu SB, Deveer R, Akin MN, Gurbuz AS, Kasap B, Guvey H. Is there any impact of copper intrauterine device on female sexual functioning? J Clin Diagn Res. 2016;10(10):QC21.
21. 21. Bolourian Z, Ganjloo J. Evaluating sexual dysfunction and some related factors in women attending Sabzevar Health Care Centers. J Reprod Infertil. 2007;8(2):163-70.
22. 22. Gulum M, Yeni E, Sahin MA, Savas M, Ciftci H. Sexual functions and quality of life in women with tubal sterilization. Int J Impot Res. 2010;22(4):267–71.
23. 23. Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175(2):654–58.
24. 24. Bastianelli, C., Farris, M., & Benagiano, G. Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center. Contraception. 2011;84(4):402–8.
25. 25. Sakinci M, Ercan CM, Olgan S, Coksuer H, Karasahin KE, Kuru O. Comparative analysis of copper intrauterine device impact on female sexual dysfunction subtypes. Taiwan J Obstet Gynaecol. 2016;55(1):30-4.
26. 26. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women:a comparative study. Contraception. 2004;69(5):407–12.
27. 27. Gomez AM, Clark JB. The relationship between contraceptive features preferred by young women and interest in IUDs:an exploratory analysis. Perspect Sex Reprod Health. 2014;46(3):157–63.
28. 28. Casey PM, MacLaughlin KL, Faubion SS. Impact of contraception on female sexual function. Journal of Women's Health. 2017 Mar 1;26(3):207-13.
29. 29. Ferreira JM, Carreiro AV, Fernandes A, Bahamondes L. Sexual function and quality of life in a cohort of Brazilian users of two kind of intrauterine contraceptives. Revista Brasileira de Ginecologia e Obstetrícia. 2019 Apr;41(4):236-41
30. 30. Toorzani ZM, Zahraei RH, Ehsanpour S, Nasiri M, Shahidi S, Soleimani B. A study on the relationship of sexual satisfaction and common contraceptive methods employed by the couples. Iran J Nurs Midwifery Res. 2010;15(3):115‐9.
31. 31. Wallwiener M, Wallwiener LM, Seeger H, Mueck AO, Zipfel S, Bitzer J, et al. Effects of sex hormones in oral contraceptives on the female sexual function score:a study in German female medical students. Contraception. 2010;82(2):155-9.
32. 32. Hamadiyan H, Asadpour Ghasem Oladi M, Rahbar P, Azad M. Prevalence of sexual dysfunction among women using contraceptive methods. International Journal of Medical Research & Health Sciences. 2016;5(12):163-7.
33. 33. Bahri N, Tohidinik HR, Bilandi RR, Larki M, Hooshangi F, Soltanian M. The relation between contraception methods and quality of life. Epidemiol Biostat Public Health. 2016;13(4):11986.
34. 34. Williams SL, Parisi SM, Hess R, Schwarz EB. Associations between recent contraceptive use and quality of life among women. Contraception. 2012;85(3):282–7.
35. 35. Leon-Larios F, Vazquez-Valeo CG, Sanchez-Sanchez A, Gomez-Baya D, Macías-Seda J, Cabezas-Palacios MN. Health-related quality of life in undergraduate women using any contraceptive. Health Qual Life Outcomes. 2019;17(1):90.
36. 36. Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175(2):654–58.
37. 37. Umran O, Melike RD. Effect of the contraceptive methods on female sexual function. Int J Caring Sci. 2016;10(3):1-366.
38. 38. Ertekin Pinar S, Demirel G, Yildirim G, Daglar G. Sexual experiences and quality of life in Turkish women using methods of contraception. J Obstet Gynaecol. 2019;39(6):782-7.